Basic Information
Healionics is a clinical-stage company dedicated to improving dialysis access for patients with kidney failure. Our novel graft vessel (artificial blood vessel) resists the blockage and infection issues associated with current devices. We also have an exciting product pipeline based on our STAR® biomaterials platform, which has the unique ability to prevent two serious problems that affect all implantable devices: scarring and infection.
Healionics Corporation
Seattle,Washington,United States of America
less than 15 people
March 01, 2007
info@healionics.com

